Methotrexate Inhibits Proteolysis of Dihydrofolate Reductase by the N-end Rule Pathway by Johnston, Jennifer A. et al.
THE JOURNAL OF BIOLOGICAL CHEMISTRY 
© 1995 by The American Society for Biochemistry and Molecular Biology, Inc. 
Vol. 270, No. 14, Issue of April 7, pp. 8172--8178, 1995 
Printed in U.S.A. 
Methotrexate Inhibits Proteolysis of Dihydrofolate Reductase by the 
N-end Rule Pathway* 
(Received for publication, September 29, 1994, and in revised form, January 13, 1995) 
Jennifer A. Johnston:!=, Erica S. Johnson§, Patrick R.H. WalleI11, and Alexander Varshavskyll 
From the Division of Biology, California Institute of Technology, Pasadena, California 91125 
The N-end rule relates the in vivo half-life of a protein to 
the identity of its N-terminal residue. In eukaryotes, the 
N-end rule pathway is a ubiquitin-dependent, protea-
some-based system that targets and processively de-
grades proteins bearing certain N-terminal residues. Arg-
DHFR, a modified dihydrofolate reductase bearing an 
N-terminal arginine (destabilizing residue in the N-end 
rule), is short lived in ATP-supplemented reticulocyte ex-
tract. It is shown here that methotrexate, which is a folic 
acid analog and high affinity ligand of DHFR, inhibits the 
degradation but not ubiquitination of Arg-DHFR by the 
N-end rule pathway. The degradation of other N-end rule 
substrates is not affected by methotrexate. We discuss 
implications of these results for the mechanism of protea-
some-mediated protein degradation. 
The surface of a protein molecule bears a number of peptide 
bonds, which are potential cleavage sites for proteases. None-
theless, only some intracellular proteins are short-lived in vivo, 
indicating that most of these solvent-exposed bonds cannot be 
cleaved by intracellular proteases. Features of a protein that 
make it short-lived in vivo or in vitro are called degradation 
signals or degrons (Varshavsky, 1991). The resistance of a long-
lived protein to proteases located in the same compartment is 
due in part to the sequence selectivity of proteases, which 
require the presence of a sequence motif or at least a specific 
residue in a substrate. In addition, the rate of peptide bond 
cleavage by even a relatively nonspecific protease depends on 
conformational flexibility of the motif that the protease recog-
nizes. For example, only some of the potential cleavage sites on 
the surface of a globular protein are cleaved efficiently by the 
bacterial metalloendoprotease thermolysin, and these pre-
ferred cleavage sites are located in exposed segments of the 
polypeptide chain which have the highest spatial mobility 
(Fontana et al., 1986). 
Thus, even if a motif recognized by a protease is present on 
the surface of a protein, conformational rigidity of this poten-
tial degron may preclude its efficient utilization by the prote-
ase. Conversely, a conformationally destabilized protein may 
acquire degrons that are masked in an unperturbed version of 
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the protein (Parsell and Sauer, 1989). This can happen not only 
through conformational relaxation of a previously rigid (and 
therefore cryptic) surface degron but also through exposure of 
degrons in previously buried regions of the protein. The mech-
anistic connection between segmental mobility of a polypeptide 
chain and its susceptibility to proteolysis stems from a scarcity 
of local chain conformations that can lend themselves to an 
optimal transition-state intermediate without a conforma-
tional adjustment (Fontana et al., 1986; Creighton, 1992; 
Hubbard et al., 1994). 
Dynamic aspects of a substrate's conformation are likely to 
play a major role in the functioning of intracellular proteolytic 
systems such as those that involve the multisubunit, multi-
catalytic protease called the proteasome (for reviews, see Lupas 
et al., 1995; Rechsteiner et al., 1993; Goldberg and Rock, 1992; 
Orlowski, 1990). A salient feature of these ATP-dependent 
systems is their processivity: once the degradation of a protein 
begins, it proceeds to completion. Thus, a proteasome-mediated 
system should be able to perturb the conformation of a globular 
protein substrate before or during its processive degradation by 
the proteasome. The "conformational" problem to be solved by 
the proteasome is analogous to the problem faced by a protein 
translocation system: components of a transmembrane channel 
must unfold a protein before or during its "threading'' across 
membrane, except that in this case the protein is transported 
rather than destroyed (Blobel, 1980; Eilers and Schatz, 1986; 
Sanders and Schekman, 1992; Arkowitz et al., 1992). 
In the present work, we show that a proteasome-based pro-
teolytic system called the N-end rule pathway is remarkably 
sensitive to alterations in the conformational stability of its 
substrates. The N-end rule relates the in vivo half-life of a 
protein to the identity of its N-terminal residue (for review see 
Varshavsky, 1992). Similar but distinct versions of the N-end 
rule operate in all organisms examined, from mammals to 
bacteria (Bachmair et al., 1986; Gonda et al., 1989; Tobias et al., 
1991). In eukaryotes, the N-end rule-based degradation signal, 
called the N-degron, comprises two determinants: a destabiliz-
ing N-terminal residue and an internal lysine (or lysines) of a 
substrate (Bachmair and Varshavsky, 1989; Johnson et al., 
1990; Hill et al., 1993). The Lys residue is the site of formation 
of a multiubiquitin chain (Chau et al., 1989). Ubiquitin (Ub) 1 is 
a protein whose covalent conjugation to other proteins (often in 
the form of a multi-Uh chain) plays a role in a number of 
processes, primarily through routes that involve protein deg-
radation (for reviews, see Ciechanover and Schwartz, 1994; 
Parsell and Lindquist, 1993; Vierstra, 1993; Jentsch, 1992; 
Varshavsky, 1992; Finley, 1992; Hochstrasser, 1992). 
The recognition of an N-end rule substrate is mediated by a 
1 The abbreviations used are: Ub, ubiquitin; MTX, methotrexate; 
DHFR, mouse dihydrofolate reductase; ha, epitope tag derived 
from hemagglutinin; Tricine, N-[2-hydroxyl-1,1-bis(hydroxymethyl)-
ethyl]glycine; PAGE, polyacrylamide gel electrophoresis; /3-gal, E. coli 
/3-galactosidase. 
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FIG. 1. Test proteins. The proteins shown (Ub-Met-eK-DHFRha, Ub-Arg-eK-DHFRha, Ub-Met-Ae-DHFRha, and Ub-Arg-lie-DHFRha) were 
expressed in E. coli, purified, and used as test substrates in ATP-supplemented reticulocyte extract (see "Materials and Methods"). DHFRha is 
DHFR whose C terminus was extended with a 14-residue sequence containing the hemagglutinin (ha) epitope (see "Materials and Methods"). The 
43-residue region (derived from E. coli Lac repressor) between the Ub and DHFRha moieties in Ub-Met-eK-DHFRha and Ub-Arg-eK-DHFRha is 
denoted by eK (Bachmair and Varshavsky, 1989; Johnson et al., 1992). The residues are numbered from a residue X at the Ub-eK junction to the 
last residue of the ha epitope in Ub-X-eK-DHFRha. The sequence of DHFR-linked eK in the present work differs from that of the /3gal-linked eK 
near the eK-reporter junction (Johnson et al., 1992). Lys-15 and Lys-17 residues are boxed in the sequence of eK. In Ub-Met-Ae-DHFRha and 
Ub-Arg-Ae-DHFRha, eK was replaced by the sequence Met/Arg-His-Gly-Ser-Gly-Ile-Met between Ub and Val, the wild-type N-terminal residue of 
mouse DHFR (Dahmen et al., 1994). 
protein called N-recognin or E3. The binding ofN-recognin to a 
substrate's destabilizing N-terminal residue is followed by the 
formation of a multi-Uh chain linked to an internal lysine of the 
substrate (the second determinant of its N-degron). A sub-
strate-linked multi-Uh chain is required for the degradation of 
at least some N-end rule substrates (Chau et al., 1989; Dohmen 
et al., 1991). In both yeast and mammals, the -200 kDa N-
recognin and a specific -20-kDa Uh-conjugating (E2) enzyme 
(one of several such enzymes in a cell) are physically associ-
ated, forming a part of a larger targeting complex (Madura et 
al., 1993; Hershko and Ciechanover, 1992). A substrate bearing 
a multi-Uh chain is transferred (presumably while still bound 
by the targeting complex) to the 26 S proteasome, a -2,000-
kDa multicatalytic protease that contains about 40 distinct 
subunits (Rechsteiner et al., 1993). The ensuing processive 
degradation of the substrate yields short ( - IO-residue) pep-
tides and regenerates Uh from a multi-Uh chain. All Uh-de-
pendent proteolytic systems, including the N-end rule path-
way, apparently share many components of the 26S 
proteasome. Differences among these pathways include their 
distinct targeting complexes, whose recognins (associated with 
specific E2s) bind to degradation signals other than N-degrons 
(Varshavsky, 1992). 
Previous studies (Gonda et al., 1989; Reiss et al., 1988) 
showed that the N-end rule pathway is active in ATP-supple-
mented extract from rabbit reticulocytes. In the present work 
we used this in vitro system and methotrexate (MTX; a folic 
acid analog and inhibitor of the enzyme dihydrofolate reduc-
tase (DHFR)), to determine whether noncovalent conforma-
tional stabilization of a protein affects its degradation by the 
N-end rule pathway. 
MATERIALS AND METHODS 
DNA Constructs-The plasmids pEJJl-R and pEJJl-M expressed, 
respectively, Ub-Arg-eK-DHFRha and Ub-Met-eK-DHFRha (Fig. 1) from 
the T7 polymerase promoter in Escherichia coli and were constructed 
using a three-part ligation as follows. (i) The pT7-7 vector (Tabor and 
Richardson, 1985) was digested with Ndel and Hindlll, and the larger 
fragment was purified by agarose gel electrophoresis, yielding the first 
of three fragments to be ligated. (ii) A fragment encoding the Ub-Arg/ 
Met portions of the above fusions was produced from the plasmid 
pLG-Ub-M-DHFR (Bachmair and Varshavsky, 1989) using polymerase 
chain reaction (Ausubel et al., 1992) and the primer 5'-GAATTC-
CATATGCAGATTTTCGTGAAGAC-3' (the underlined sequence is the 
Ndel site, whose ATG is the start codon of the UB/4 gene (Ozkaynak et 
al., 1987)). The 3'-primer for this polymerase chain reaction encom-
passed the Bglll site near the junction between sequences encoding the 
eK extension (Fig. 1) and DHFR. (iii) The third fragment to be ligated, 
encoding eK·DHFRha, was a -600-base pair BamHl-Hindlll fragment 
derived from pLG-Ub-M-DHFRha (Johnson, 1992). Ligation of these 
three fragments (the second one encoding either Arg or Met at the 
Ub-eK junction) yielded pEJJl-R and pEJJl-M, encoding, respectively, 
Ub-Arg-eK-DHFRha and Ub-Met-eK-DHFRha. The plasmids pPJJl-R 
and pPJJl-M, expressing, respectively, Ub-Arg-Ae-DHFRha and Ub-
Met-Ae-DHFRha (Fig. 1), were produced from pEJJl-R and pEJJl-M 
by excising their BamHl-Hindlll fragment (encoding eK-DHFRha) and 
replacing it with a -600-base pair fragment of pPWl 7-R (Dohmen et 
al., 1994), which encoded Arg-His-Gly-Ser-Gly-Ile-Met-DHFRha. 
E.coli JMl0l and DH5a (Ausubel et al., 1992) were used as hosts in 
plasmid construction and in plasmid preparation for sequencing, re-
spectively. The final constructs were verified by restriction mapping 
and nucleotide sequencing (Ausubel et al., 1992). E. coli BL21(DE3) 
(Studier and Moffat, 1986) was used for overexpression of DHFR-con-
taining fusions. 
Ub-X-DHFRha Test Proteins-Unless stated otherwise, all proce-
dures were carried out at 4 °C. 0.5 ml of an overnight culture of E. coli 
BL21(DE3) carrying one of the pT7-based plasmids was diluted into 50 
ml of Luria broth containing ampicillin at 75 µg/ml, and the culture was 
grown at 37 °C to an A 600 of -0.2; more ampicillin was then added, to a 
final concentration of 115 µg/ml, and the incubation was continued 
until an A600 of -0.6. lsopropyl-l-thio-/3-n-galactopyranoside was then 
added to a final concentration of 0.2 mM. The culture was grown for 
another 25 min at 30 °C. The cells were harvested by centrifugation at 
4,000 X g for 10 min; washed twice with M9 buffer (Ausubel et al., 
1992); resuspended in 1 ml of M9 supplemented with 0.22% glucose, 
rifampicin (0.2 mg/ml), ampicllin (75 µg/ml), and 0.1% methionine 
assay medium (Difeo); and incubated with 0.5 mCi of Tran 35 S-label 
(ICN) for 10 min at 30 °C. The cells were collected by centrifugation, 
washed once with Luria broth, twice with M9 buffer, and resuspended 
in 0.5 ml of 25% (w/v) sucrose, 50 mM Tris-HCI, pH 8.0. 0.1 ml of a 
lysozyme solution (10 mg/ml in 0.25 M Tris-HCI, pH 8.0) was then 
added. After 5 min at room temperature, 0.8 ml of the lysis buffer (1 % 
Triton X-100, 37 mM Na-EDTA, 50 mM Tris-HCI, pH 8.0) was added, 
and the suspension was vortexed for 10 s twice, followed by a quick 
freezing in liquid N 2 and thawing of the sample in a 37 °C bath. The 
lysate was centrifuged at 40,000 X g for 25 min, and Ub-X-DHFRha 
(this term denotes both Ub-X-eK-DHFRha and Ub-X-Ae-DHFRha; Fig. 
1) in the supernatant was bound to the monoclonal anti-ha antibody 
12CA5 (Field et al., 1988; Johnson et al., 1992), added as an ascitic fluid, 
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in a roughly 100-fold molar excess over Ub-X-DHFRha. The antibody-
bound Ub-X-DHFRha was immobilized on a 0.5-ml column of protein 
A-Sepharose (Repligen, Cambridge, MA). The column was washed with 
5 ml of 10 Il1M sodium phosphate buffer, pH 7.5. Ub-X-DHFRha was 
eluted with 2.5 M LiCl in the same buffer. The sample was dialyzed 
overnight against 50 mM Tris-HCl, pH 7.5, then concentrated by dial-
ysis for -20 h against 50% (v/v) glycerol, 0.1 mM EDTA, 1 mM dithio-
threitol, 1 mM MgCl 2 , 50 Il1M Tris-HCl, pH 7.5, and stored at -20 °C. 
The specific radioactivity of 35 S-labeled Ub-X-DHFRha was -10 4 cpm/ 
µg. Protein concentrations were determined using the Bradford (Coo-
massie Blue) assay (Pierce). Ub-DHFR fusions purified as described 
above were conformationally unperturbed in that they could be retained 
on an MTX-Sepharose column (Pierce). 
In Vitro Assays with Reticulocyte Extract-Rabbit reticulocytes were 
purchased from Green Hectares (Oregon, WI) and shipped overnight on 
ice. ATP-depleted reticulocyte extract was prepared as described by 
Gonda et al. (1989) and stored as 0.2-ml samples in liquid N2 • Only 
once-frozen samples were used in all experiments. An assay mixture 
contained 75 µl of the extract, 10 µl of an 36 S-labeled Ub-X-DHFRha, 
0.1 mM dithiothreitol, 5 mM MgC12 , 0.8 mM ATP, and an ATP-regener-
ating system (10 mM creatine phosphate, 0.1 mg/ml creatine phosphoki-
nase). Assays were performed as follows. A reaction mixture complete 
except for ATP and the ATP-regenerating system was incubated for 10 
min at 37 °C to allow for the deubiquitination of a Ub-X-DHFRha fusion 
protein; an aliquot was then withdrawn (time zero in Figs. 2 and 3), 
ATP and an ATP-regenerating system were added to start ATP-depend-
ent reactions in the extract, and the incubation continued at 37 °C. 
The initial concentration of an 35 S-labeled Ub-X-DHFRha in the 
extract was -5 µg/ml; control experiments (not shown) indicated that 
this concentration was not rate-limiting for the degradation of either 
Arg-eK-DHFRha or Arg-~e-DHFRha. MTX (where indicated) was added 
from a 2 M stock solution in 0.2 M NaOH to Ub-X-DHFRha in a reaction 
tube and incubated for 5 min at O °C before assembling the reaction 
mixture as described above. The final MTX concentration was 20 µM. 
Two equal samples were withdrawn from reaction tubes at the times 
indicated in the legends to Figs. 2 and 3. One sample was assayed for 
the amount of 5% trichloroacetic acid-soluble 36 S, and the other was 
examined by a Tricine buffer-based SDS-PAGE (9% acrylamide, 0.24% 
bisacrylamide) (Schiigger and Jagow, 1987). The gels were analyzed 
using fluorography or Phosphorlmager (Molecular Dynamics, Sunny-
vale, CA). Trichloroacetic acid-soluble 36 S was determined as follows. 
0.1 ml of a solution of bovine serum albumin (50 mg/ml) was added to a 
10-µl sample; 0.11 ml of 10% trichloroacetic acid was then added; the 
sample was incubated on ice for 10 min, followed by centrifugation at 
12,000 X g for 5 min. 36 S in the supernatant was determined using a 
water-compatible scintillation mixture and a scintillation counter. In 
each of the graphs of Fig. 3, the amount of trichloroacetic acid-soluble 
35 S in a zero-point sample (before the addition of ATP; 5-10% of total 
36 S) was subtracted from the values for samples withdrawn at later 
times. 
RESULTS 
Linear Uh fusions are rapidly cleaved in vivo or in cell-free 
extracts after the last residue of Uh, making possible the pro-
duction of otherwise identical proteins bearing different N-
terminal residues (Bachmair et al., 1986; Baker et al., 1992). In 
one application of this method, Gonda et al. (1989) incubated 
fusions of Uh to E. coli /3-galactosidase (Ub-X-/3gal) in reticulo-
cyte extract, producing X-f3gal test proteins bearing different 
N-terminal residues. Depending on the identity of a residue X, 
an X-/3gal is either short-lived or metabolically stable in ATP-
supplemented extract (Gonda et al., 1989), similar to the in vivo 
findings with the same X-f3gals in the yeast Saccharomyces 
cerevisiae (Bachmair et al., 1986). Mutational analysis has 
shown that either one of two lysines (Lys-15 or Lys-17) in a 
non-f3gal N-terminal region of an X-f3gal test protein was also 
required for rapid degradation of X-f3gal by the N-end rule 
pathway (Fig. 1) (Bachmair and Varshavsky, 1989; Johnson et 
al., 1990). The function of these lysines was revealed by the 
finding that Lys-15 or, alternatively, Lys-17, is the site of 
formation of a multi-Uh chain (Chau et al., 1989). The non-f3gal, 
-40-residue extension at the N terminus of f3gal was derived 
in part from an internal sequence of E. coli Lac repressor 
(Bachmair and Varshavsky, 1989). 
In the present work, the strategy used by Gonda et al. (1989) 
with f3gal-based substrates was employed to examine the deg-
radation of similarly designed DHFR-based substrates by the 
N-end rule pathway in reticulocyte extract. The -40-residue 
N-terminal extension of DHFR, derived from X-f3gal test pro-
teins (Fig. 1) (Bachmair and Varshavsky, 1989), is denoted 
below as eK (extension (e) containing lysine (K)) (Johnson et al., 
1992). In the constructs of Fig. 1, the C terminus of Ub-X-eK-
DHFR was extended with a 14-residue sequence containing ha, 
an epitope tag derived from the influenza virus hemagglutinin, 
which could be recognized by a monoclonal antibody (Field et 
al., 1988; Johnson et al., 1992). Two fusion proteins, Ub-Met-
eK-DHFRha and Ub-Arg-eK-DHFRha (Fig. 1), bore, respec-
tively, Met and Arg, a stabilizing and a destabilizing residue at 
the junction between Uh and the rest of a fusion (Varshavsky, 
1992). These proteins were overexpressed in E. coli, labeled in 
vivo with [35 S]methionine, and purified by affinity chromatog-
raphy, using anti-ha antibody (see "Materials and Methods"). 
Ub-Met-eK-DHFRha and Ub-Arg-eK-DHFRha were rapidly 
deubiquitinated upon addition to ATP-depleted reticulocyte ex-
tract, yielding, respectively, Met-eK-DHFRha and Arg-eK-DH-
FRha (Fig. 2, A and B, lanes a and b), analogous to the previ-
ously characterized deubiquitination of Ub-X-eK-f3gal fusions 
under the same conditions (Gonda et al., 1989). Both Met-eK-
DHFRha and Arg-eK-DHFRha remained metabolically stable 
in ATP-depleted extract (data not shown), but the addition of 
ATP resulted in a much faster degradation of Arg-eK-DHFRha 
than Met-eK-DHFRha, which remained long lived in ATP-sup-
plemented extract (Fig. 2, A and B, lanes b-e, and Fig. 3A). The 
metabolic fates ofDHFR-based test proteins were monitored by 
SDS-PAGE (Fig. 2) and also by measuring the amount ofacid-
soluble 35 S released during the incubation of an 35 S-labeled 
protein in ATP-supplemented extract (Fig. 3). 
As shown in Fig. 3A, 33% of the initially present 35 S-labeled 
Arg-eK-DHFRha was degraded to acid-soluble fragments in 
ATP-supplemented reticulocyte extract after a 30-min incuba-
tion. By contrast, only 6% of the otherwise identical Met-eK-
DHFRha, bearing an N-terminal Met (stabilizing residue in the 
N-end rule), was degraded after a 30-min incubation (Fig. 3A). 
Analysis by SDS-PAGE showed a transient accumulation of 
multiply ubiquitinated Arg-eK-DHFRha derivatives and a de-
crease in intensity of the band of unmodified Arg-eK-DHFRha 
in the course of its incubation in ATP-supplemented extract 
(Fig. 2B). By contrast, Met-eK-DHFRha was neither ubiquiti-
nated nor significantly degraded in ATP-supplemented extract 
(Fig. 2A), in agreement with the findings about similarly de-
signed X-/3gal substrates (Gonda et al., 1989). 
Previous work has shown that an amino acid derivative such 
as a dipeptide that bears a destabilizing N-terminal residue 
can inhibit the degradation of a f3gal-based N-end rule sub-
strate either in vitro (reticulocyte extract) (Gonda et al., 1989) 
or in vivo (yeast cells) (Baker and Varshavsky, 1991). As shown 
in Figs. 2C and 3A, the degradation of a DHFR-based N-end 
rule substrate such as Arg-eK-DHFRha in reticulocyte extract 
was almost completely inhibited by the Arg-Ala dipeptide. 
Dipeptides bearing destabilizing N-terminal residues inhibit 
the N-end rule pathway by competing with N-end rule sub-
strates for binding to N-recognin (Reiss et al., 1988; Gonda et 
al., 1989; Baker and Varshavsky, 1991). Arg-Ala not only pre-
cluded the degradation of Arg-eK-DHFRha (Fig. 3A) but also 
inhibited its ubiquitination (Fig. 2C), indicating that Arg-Ala 
blocks a step in the N-end rule pathway which precedes the 
ubiquitination step. 
We asked whether the folate analog MTX, a high affinity 
DHFR ligand (Kd of -10- 11 M) and a competitive inhibitor of 
DHFR (Matthews et al., 1985), would affect the degradation of 
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FIG. 2. Effect of MTX on the degradation of DHFR-based N-end rule substrates in reticulocyte extract. Panel A: lane a, purified, 
35 S-labeled Ub-Met-eK-DHFRha (the amount of substrate added to this lane and analogous lanes in other panels was larger than the initial 
amounts of substrate in lane b and analogous lanes). Lane b, Ub-Met-eK-DHFRha was added to ATP-depleted reticulocyte extract and incubated 
for 10 min at 37 °C (time zero sample). Lanes c-e, same as lane a, but the samples were withdrawn and analyzed by SDS-PAGE 15, 30, and 60 
min after the addition of ATP at time zero (see "Materials and Methods"). Panel B: same as panel A but with Ub-Arg-eK-DHFRha. Panel C: same 
as panel B, but the Arg-Ala dipeptide was added to reticulocyte extract (to the final concentration of 10 mM) together with Ub-Arg-eK-DHFRha. 
Panel D: lanes a-e, same as panel B, but the data are from another experiment. Lanes f-i, same as lanes b-e, but the assay was carried out in the 
presence of 20 µM MTX (see "Materials and Methods"). Panel E: lane a, purified, 35 S-labeled Ub-Arg-6.e-DHFRha. Lanes b-d, same as lanes b-d 
in panel A, but the assay was carried out with Ub-Arg-6.e-DHFRha, and the incubation times were 0, 10, and 30 min (after the addition of ATP). 
Lanes e-h, same as lanes a-d, but the assay was carried out in the presence of20 µM MTX. Arrowheads and arrows indicate, respectively, the bands 
of 36-kDa Ub-X-eK-DHFRha fusions and their 28-kDa deubiqwtinated derivatives, X-eK-DHFRha (Ub-Arg-6.e-DHFRha and Arg-6.e-DHFRha in 
panel E). Asterisks indicate the band of 8-kDa Ub, produced by deubiquitination of 35 S-labeled Ub-X-eK-DHFRha and Ub-Arg-6.e-DHFRha. 

















FIG. 3. Degradation of DHFR-based 
N-end rule substrates in reticulocyte 
extract, measured by determining ac-
id-soluble 35 S. Panel A: □, Met-eK-DH-
FRha; ♦, Arg-eK-DHFRha; x, Arg-eK-
DHFRha in the presence of 1 mM Arg-Ala 
dipeptide; 0, Arg-eK-DHFRha in the 
presence of20 µM MTX. Panel B: □, same 
as in panel A but from another experi-
ment with Met-eK-DHFRha; ♦, Arg-eK-
DHFRha; e, Arg-6.e-DHFRha; 0, Arg-6.e-
DHFRha in the presence of 20 µM MTX. 
Each decay curve was determined at least 
three times, in independent experiments, 
with the results differing by less than 
15% for each of the time points. See 
"Materials and Methods" for the defini-




a DHFR-based N-end rule substrate. Remarkably, the presence 
ofMTX in ATP-supplemented reticulocyte extract resulted in a 
nearly complete inhibition of Arg-eK-DHFRha degradation 
(Fig. 3A). The inhibitory effect of MTX was confined to the 
actual proteolysis of Arg-eK-DHFRha: its multiubiquitination 
was in fact enhanced by MTX, in contrast to the effect of 
Arg-Ala, which inhibited both the degradation and ubiquitina-
tion of Arg-eK-DHFRha (Fig. 2D; compare with Fig. 2C). 
We also determined the effect of MTX on degradation of 
Arg-Ae-DHFRha (derived from Ub-Arg-6.e-DHFRha), which 
lacked most of the -40-residue, lysine-containing eK extension 
of Arg-eK-DHFRha (Fig. 1). Previous work has shown that 
Arg-6.e-DHFRha is much longer lived than Arg-eK-DHFRha in 
the yeast S. cereuisiae at 30 °C (t 112 of more than 4 h uersus -10 
min, respectively); it has also been shown that a major reason 
for the increased metabolic stability of Arg-Ae-DHFRha is the 
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absence of Lys-15 and Lys-17 residues: Arg-eaK_DHFRha, 
which contains Arg instead of Lys at positions 15 and 17 of the 
otherwise unaltered eK extension, is nearly as long-lived in 
yeast as Arg-Ae-DHFRha (Bachmair and Varshavsky, 1989). In 
a qualitative agreement with these in vivo data, Arg-Ae-DH-
FRha was degraded more slowly than Arg-eK-DHFRha in ATP-
supplemented reticulocyte extract (Fig. 3B). The degradation of 
Arg-Ae-DHFRha was mediated by the N-end pathway, inas-
much as Met-Ae-DHFRha, bearing a stabilizing N-terminal 
residue, was degraded at a much lower rate than Arg-Ae-
DHFRha (data not shown). 
Similarly to the findings with Arg-eK-DHFRha (Figs. 2D and 
3A), the addition of MTX almost completely inhibited the deg-
radation of Arg-Ae-DHFRha in ATP-supplemented reticulocyte 
extract (Fig. 3B). In contrast to the extensive ubiquitination of 
Arg-eK-DHFRha prior to its degradation (Fig. 2, B and D), the 
degradation of Arg-Ae-DHFRha was not accompanied by a 
significant accumulation of its multiubiquitinated derivatives, 
and no enhancement ofmultiubiquitination of Arg-Ae-DHFRha 
could be detected in the presence of MTX as well (Fig. 2E). 
The effect of MTX was confined to DHFR-based substrates: 
in parallel assays with /3gal-based N-end rule substrates such 
as Arg-eK-/3gal (Gonda et al., 1989), the addition ofMTX did not 
alter the kinetics of Arg-eK-/3gal degradation (data not shown). 
DISCUSSION 
The MTX-DHFR assay has been used previously to address 
the mechanistic and kinetic aspects of protein translocation 
across membranes (Eilers and Schatz, 1986, 1988; Vestweber 
and Schatz, 1988; Wienhues et al., 1991; Arkowitz et al., 1992). 
The present work extends the applications of MTX-DHFR to 
the problem of Uh-dependent protein degradation. We report 
the following results. 
1) Arg-eK-DHFRha (Fig. 1) is degraded by the N-end rule 
pathway in ATP-supplemented reticulocyte extract in the ab-
sence but not in the presence of MTX, a folic acid analog and a 
competitive inhibitor ofDHFR which binds to mammalian DH-
FRs with a Kd of-10- 11 M (Fig. 3A). 
2) The effect of MTX is confined to DHFR-based substrates, 
in that the degradation of other N-end rule substrates such as 
Arg-eK-/3gal is not inhibited by MTX. 
3) The degradation of Arg-eK-DHFRha (this work) and other 
N-end rule substrates (Gonda et al., 1989) in reticulocyte ex-
tract is highly processive: no degradation intermediates could 
be detected by SDS-PAGE in the course of proteolysis. 
4) MTX inhibits the degradation but not ubiquitination of 
Arg-eK-DHFRha, whose multiubiquitinated derivatives be-
come more abundant in the presence of MTX (Fig. 2D). Previ-
ous work (Chau et al., 1989; Bachmair and Varshavsky, 1989) 
has shown that the degradation of N-end rule substrates such 
as Arg-eK-/3gal and Arg-eK-DHFRha requires (and is preceded 
by) the formation of a multi-Uh chain linked to one of two 
lysines (Lys-15 or Lys-17) in the -40-residue extension (eK) at 
the N terminus of Arg-eK-DHFRha. 
5) Arg-Ae-DHFRha, which lacks the eK extension, is also 
degraded (at a lower rate than Arg-eK-DHFRha) by the N-end 
rule pathway in reticulocyte extract, and this degradation is 
also inhibited by MTX (Fig. 3B). Only traces of multiubiquiti-
nated Arg-Ae-DHFRha derivatives were observed during its 
degradation by the N-end rule pathway, and the relative con-
tent of these derivatives was further decreased in the presence 
of MTX (Fig. 2E and data not shown). 
The extensive ubiquitination of Arg-eK-DHFRha prior to its 
degradation indicates that ubiquitination is not rate-limiting 
for the degradation of Arg-eK-DHFRha in reticulocyte extract. 
By contrast, the scarcity of ubiquitinated derivatives of Arg-
Ae-DHFRha suggests that ubiquitination of Arg-Ae-DHFRha is 
among the slowest steps that precede its degradation by the 
N-end rule pathway. A likely explanation for these differences 
between Arg-eK-DHFRha and Arg-Ae-DHFRha is the differ-
ence in locations of multi-Uh chains attached to these sub-
strates: in Arg-eK-DHFRha, a multi-Uh chain is linked to one of 
the sterically accessible lysines (Lys-15 or Lys-17) in a flexible 
N-terminal extension (eK) located outside of the folded DHFR 
globule (Fig. 1) (Bachmair and Varshavsky, 1989). By contrast, 
in the case of Arg-Ae-DHFRha a multi-Uh chain must form on 
one of the numerous but relatively immobile and (presumably) 
unfavorably located lysines of the folded DHFR globule 
(Dohmen et al., 1994), thus accounting for both the lower over-
all rate of Arg-Ae-DHFRha degradation and the low steady-
state content of its ubiquitinated derivatives. This interpreta-
tion also accounts for the observed difference in the effect of 
MTX on the relative abundance of multiubiquitinated Arg-eK-
DHFRha and Arg-Ae-DHFRha. Indeed, a block to Arg-eK-DH-
FRha degradation due to a conformational stabilization of its 
DHFR moiety by MTX would not be expected to perturb the 
formation of a multi-Uh chain linked to the eK extension of 
DHFR, as observed. By contrast, a multi-Uh chain linked to 
Arg-Ae-DHFRha has to form on a lysine of the folded DHFR 
moiety. This is a slow step, whose rate is further decreased in 
the presence of MTX, which stabilizes the conformation of 
DHFR (Matthews et al., 1985; Eilers and Schatz, 1988). (It is 
assumed that the rate of formation of a multi-Uh chain linked 
to Arg-Ae-DHFRha is limited by the rate of chain initiation at 
one of the lysines of DHFR.) 
A model that accounts for the findings of this work and is 
consistent with other evidence is shown in Fig. 4. A major 
assumption is that the initiation of processive degradation of 
an N-end rule substrate such as Arg-eK-DHFRha requires at 
least a local conformational perturbation of the folded DHFR 
moiety which can be "utilized" by the proteasome. The proba-
bility of this perturbation would be decreased in the presence of 
MTX, which stabilizes the folded conformation of DHFR. Since 
MTX inhibits the degradation but not multiubiquitination of 
Arg-eK-DHFRha, the relevant conformational perturbation 
must be a step that occurs after but not before the ubiquitina-
tion step (Fig. 4). It is not specified whether this "sufficient" 
perturbation ofDHFR is a thermally driven fluctuation or is at 
least in part the result of DHFR interactions with components 
of the N-end rule pathway, including a DHFR-linked multi-Uh 
chain; the model is consistent with either possibility. Another 
assumption of the model is that an interaction between a ubiq-
uitinated Arg-eK-DHFRha substrate and the proteasome-based 
proteolytic machine is reversible, in that a substrate-protea-
some complex dissociates (or enters a state that cannot result 
in proteolysis; see below) after a stochastically determined time 
interval (Fig. 4). 
Given these assumptions, the near cessation of degradation 
of DHFR-based N-end rule substrates in the presence of MTX 
is explained as follows. In the absence of MTX, the mean time 
interval between the formation of a substrate-proteasome com-
plex and a relevant conformational perturbation of DHFR 
within the complex is either close to or shorter than the mean 
lifetime of the complex. In the presence of MTX, its binding to 
DHFR (and the resulting conformational stabilization of the 
DHFR globule) decreases the probability of a relevant pertur-
bation of DHFR within the substrate-proteasome complex but 
does not influence the mean lifetime of the complex (Fig. 4). 
Specifically, the time interval before perturbation of the sub-
strate is postulated to become significantly longer than the 
time interval before dissociation of the substrate-proteasome 
complex, resulting in abortive cycles of targeting and multi-
ubiquitination but little net degradation of a DHFR-based 






FIG. 4. On the mechanism of MTX effect. Each of the four depicted transitions (I-IV) in the N-end rule pathway is actually a multistep 
reaction (Varshavsky, 1992). The shapes of structures are arbitrary. Among the protein-protein complexes shown in this diagram, the interactions 
between N-recognin (N-r) and the Uh-conjugating enzyme (E2), and between N-recognin and a DHFR-based N-end rule substrate were demon-
strated directly (Bartel et al., 1990; Madura et al., 1993). By contrast, a direct interaction between N-recognin and proteasome is a conjecture that 
remains to be verified. The path of a multi-Uh chain (black ovals) in a complex between proteasome and a multiubiquitinated substrate is unknown. 
However, if the E2 enzyme that initiates the formation of a substrate-Jinked multi-Uh chain is also responsible for the chain elongation, the 
growing tip of the chain must be in proximity to this E2, as shown in the diagram. Superimposition of the substrate and proteasome denotes a 
complex (of unknown structure) between them. A DHFR-based N-end rule substrate such as Arg-eK-DHFRha (Fig. 1), bearing a destabilizing 
N-terminal residue (d) and a mobile lysine residue (K) outside of the folded DHFR globule, is bound by a complex of N-recognin and E2 (step I). 
Formation of a lysine-linked multi-Uh chain (the chain's length is arbitrarily set at five Ub moieties) and the binding of a multiubiquitinated 
substrate by the proteasome take place at step II. In vitro, the multiubiquitination of an N-end rule substrate can occur in the absence of 
proteasome; however, it is possible that the binding of a targeted substrate by the proteasome accompanies or even precedes the substrate's 
multiubiquitination in vivo. At step III, a local or a global conformational perturbation ofDHFR in a complex with the proteasome occurs, resulting 
in proteolysis (the irreversible step IV), which yields short fragments of DHFR and regenerates Ub from a multi-Uh chain. Formation of the 
MTX·DHFR complex stabilizes the folded DHFR conformation, decreasing the probability of a conformational perturbation of DHFR (step Ill) 
which can be utilized by the proteasome and thereby inhibiting the degradation of a DHFR-containing substrate. In the case of a protein such as 
Arg-Lie-DHFRha (Fig. 1), which lacks a targetable lysine residue outside of the DHFR globule, the binding ofMTX and the resulting conformational 
stabilization of DHFR suppress both ubiquitination and degradation of Arg-Lle-DHFRha. See "Materials and Methods" for further details. 
N-end rule substrate, as observed. 
The understanding of proteasome mechanics is still rudi-
mentary, and therefore the model of Fig. 4 is vague about 
details of the MTX effect. To cite just one example, the postu-
lated "dissociation" of a substrate-proteasome complex may 
actually be less than a complete dissociation: for the model to 
be relevant, it is sufficient that the complex can enter a state in 
which the proteasome becomes unable to initiate the degrada-
tion of a DHFR-based substrate upon an otherwise sufficient 
perturbation of DHFR. 
The degradation of DHFR-based N-end rule substrates in 
vivo (in S. cerevisiae cells) was found to be at most weakly 
inhibited by the addition of MTX to the growth medium. 2 
However, in contrast to the above in vitro assays (Figs. 2 and 
3), in which the N-end rule pathway targets a previously syn-
thesized, folded DHFR, in the in vivo assays the binding of 
MTX to a nascent DHFR-based substrate takes place in kinetic 
competition with the targeting of the same substrate by the 
N-end rule pathway. Moreover, while the binding of MTX re-
quires the folded DHFR conformation, the targeting by the 
N-end rule pathway is expected to occur at any time after the 
(cotranslational) formation of a destabilizing residue at the N 
terminus of a substrate. A strategy in which the N-end rule 
pathway is repressed at first (in a specially constructed yeast 
strain) and then induced should eliminate the above kinetic 
competition and allow the effects of MTX to be tested in vivo 
under conditions in which a DHFR-based substrate is folded 
and MTX-bound before it is targeted by the N-end rule path-
way. These experiments are in progress. Interestingly, the in 
vivo degradation of a DHFR-based N-end rule substrate whose 
DHFR moiety was fused to an unrelated protein such as S. 
cerevisiae Cdc28p (Dohmen et al., 1994) could be inhibited by 
MTX, in contrast to the degradation of an otherwise identical 
substrate lacking the Cdc28p domain. 2 The role of a DHFR-
linked protein in conferring the sensitivity to inhibition by 
MTX remains to be understood. 
The ability to suppress the in vivo degradation of a short 
2 J. Johnston and A Varshavsky, unpublished data. 
lived protein with its cell-penetrating, low Mr ligand would 
have a number of applications, including the possibility of 
constructing new types of conditional mutants (Dohmen et al., 
1994). 
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